HK Inno.N (INNO KS): On a Solid Growth Path with Blockbuster New Drug K-CAB
K-CAB has already become the no. 1 drug in Korean digestive treatment market. Thus far, K-CAB has marketing partnerships with 24 countries.
635 Views
BNC Korea (256840 KS): Oral COVID-19 Treatment No More Remains a Catalyst
In-licensed oral COVID-19 treatment no longer remains a catalyst after competitor's encouraging clinical trial results. Other oral treatments are...
258 Views
JHBP Holdings (Genor Biopharma) IPO Initiation: Hunting for a Cure
$ Genor Biopharma is a biopharmaceutical company focusing on developing and commercializing oncology and autoimmune drugs. Its drug candidates...
589 Views
PharmaSGP IPO Initiation: Potent Medicine
PharmaSGP (1780644D GR) is a pure-play consumer health company with a broad portfolio of leading chemical-free non-prescription pharmaceuticals...
537 Views
Versum Materials - Merck KGaA Dials Up the Pressure and Launches Unsolicited Tender Offer (Part III)
Merck KGaA (MRK GR) took off the gloves yesterday in its pursuit of Versum Materials (VSM US) , announcing and launching an unsolicited, fully...
903 Views